TGFB1 and neoplasm: In melanoma, high levels of IL-37 expressed by peripheral Tregs were found to mirror the secretion of IL-1β mediators, especially TGFβ, by the tumor, suggesting it could be used as a possible biomarker for tumor-induced immunosuppression [27].